The procedure utilizes a patient's own adipose tissue-derived cellular fraction and is considered for selected cases of Avascular Necrosis (AVN) of the hip as part of a joint-preserving treatment approach.
Treatment suitability is determined through detailed clinical and imaging evaluation.
